University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
CSE Journal Articles

Computer Science and Engineering, Department of

2-15-2013

Data mining the functional characterizations of
proteins to predict their cancer-relatedness
Peter Revesz
University of Nebraska-Lincoln, prevesz1@unl.edu

Christopher Assi
University of Nebraska-Lincoln, cassi@cse.unl.edu

Follow this and additional works at: http://digitalcommons.unl.edu/csearticles
Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons,
Congenital, Hereditary, and Neonatal Diseases and Abnormalities Commons, Databases and
Information Systems Commons, Disease Modeling Commons, Health Information Technology
Commons, Medical Genetics Commons, and the Oncology Commons
Revesz, Peter and Assi, Christopher, "Data mining the functional characterizations of proteins to predict their cancer-relatedness"
(2013). CSE Journal Articles. 147.
http://digitalcommons.unl.edu/csearticles/147

This Article is brought to you for free and open access by the Computer Science and Engineering, Department of at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in CSE Journal Articles by an authorized administrator of DigitalCommons@University of
Nebraska - Lincoln.

INTERNATIONAL JOURNAL OF BIOLOGY AND BIOMEDICAL ENGINEERING

Data Mining the Functional Characterizations of
Proteins to Predict their Cancer-Relatedness
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whereas most data mining and machine learning algorithms
assume relational database inputs. We overcame this problem
by describing effecting ways to restructure the protein
databases into relational databases. The restructured databases
allowed the use of several types of classifiers, such as, Support
Vector Machines (SVMs) and decision trees. Other types of
data mining algorithms could be also used, but we chose these
two types because they are currently the most frequently used
data mining methods.
This paper is organized as follows. Section II describes
some basic background. Section III presents the experimental
results of applying the J48 decision tree and the libSVM
classifiers to the restructured pancreatic cancer database.
Section IV gives a detailed analysis of the prostaglandin
protein synthesis network. Section V discusses the results.
Finally, Section VI gives our conclusions and possible
directions for future work.

I. INTRODUCTION

II. BACKGROUND CONCEPTS AND TOOLS

Data mining is increasingly applied to non-relational
databases, including genome and protein databases [1]--[5].
Data mining and data classification methods are developed for
protein structure and function [6]--[8], protein evolution [9],
[10], protein interaction networks [11], and medical data that
may include genomes or proteins [12]--[14]. In the present
paper, preliminary versions of which were presented in [15]
and [16], we focus on a pancreatic cancer protein database.
This database was collected by Robert Powers and Bradley
Worley, in the Department of Chemistry at the University of
Nebraska-Lincoln, based on earlier pancreatic cancer research
[17]--[23].
Pancreatic cancer was chosen as a test case because it has
the lowest survival rate among different types of cancer. Data
mining was used to investigate the relationship among
anomalous proteins, which have unusually high or low levels
in pancreatic patients. Early recognition of some patterns
developing among these anomalous proteins may allow
treatment to start earlier and increase the survival rate of
pancreatic cancer patients.
Data mining of protein databases poses special challenges
because many protein databases often contain set data types,

In this section, part A gives an introduction to classifiers
and part B describes the WEKA system that contains a library
of implemented classifiers.

Abstract—This paper considers two types of protein data.
First, data about protein function described in a number of
ways, such as, GO terms and PFAM families. Second, data
about whether individual proteins are experimentally
associated with cancer by an anomalous elevation or lowering
of their expressions within cancerous cells. We combine these
two types of protein data and test whether the first type of data,
that is, the functional descriptors, can predict the second type
of data, that is, cancer-relatedness. By using data mining and
machine learning, we derive a classifier algorithm that using
only GO term and PFAM family descriptions of a protein can
predict with over 73 percent accuracy whether it is associated
with pancreatic cancer.

A. Classifiers
Let R(x1,…,xn, y) be a relation, where the set of attributes X
= {x1,…,xn} is called the feature space and the y attribute is
called a label. Each tuple of the relation describes some entity
based on specific values of the feature space and the label. For
example, each row may describe a protein with specific feature
attributes, such as, molecular weight, amino acid sequence
etc., and a label attribute, such as, whether it is involved in
pancreatic cancer.
Given such a relation R, a classifier is mapping from X to y.
If a classifier is correct on all tuples of relation R, then the
value of y can be always predicted from the values of X. In
practice, the classifier may not be correct on all proteins.
Further, classifiers are intended to be able to classify even
those proteins that are new, not just those that are already in R.
Popular classifiers include decision trees and Support Vector
Machines (SVMs). A decision tree is a tree which is read from
the root towards the leaves, and whose internal nodes are tests
and whose leaf nodes are categories [24]. For example, C4.5
is a well-known decision tree algorithm [25]. SVMs perform
classification by constructing for relation R an n-dimensional
hyperplane that optimally separates the data into two
categories (for example when y = 0 and y = 1). An example of
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proteins. We merged the GO_np and GO_pdac tables without
losing the information whether the protein is related to cancer
or not. Hence we extended the GO_np and the GO_pdac tables
with a Y column, which denotes whether the protein is related
to pancreatic cancer or not. All the proteins in the GO_np table
are extended with a Y value of "0", while all the proteins in the
GO_pdac table are extended with a Y value of "1" by the
following SQL query, which we call SQL 1 in Fig. 1:

SVM is the libSVM implementation [26].
B. The WEKA Library
In our experiments we used the Waikato Environment for
Knowledge Analysis (WEKA) system developed at the
University of Waikato [27], [28]. WEKA provides an
extensive library of data mining and machine learning
algorithms. In WEKA, the input data is a relation or table
which is represented by an Attributes Relation File Format
(ARFF) file. Each ARFF file starts with a title to let the user
know what kind of data is stored in the file. The title is
followed by a relation type and then all the attributes and their
types. Finally, the attribute declarations are followed by the
actual data rows.

create view GO_merge (UID, GO, Y) as
select UID, GO, 0 from GO_np
union
select UID, GO, 1 from GO_pdac;
After the above query is executed the GO_merge table looks
as follows:
Table 2 The GO_merge table.

C. The Restructuring Method in Theory
In the pancreatic protein database collection of about eighty
tables, we chose for our study the GO_np and PFAM_np
tables, which contain data about pancreatic proteins that are
not involved in cancer, and the GO_pdac and PFAM_pdac
tables, which contain data about pancreatic proteins that are
related to pancreatic cancer. GO_np had 70,331, PFAM_np
had 7,054, GO_pdac had 30,888, and PFAM_pdac had 7,272
rows, that is, a total number of 115,545 rows. A simplified
version of the GO_pdac looks as follows:

UID
O43491
O43491
O43491
O43491
O43491
O43491
Q96C24
Q96C24
Q96C24
Q96C24
Q96C24
…

Table 1 The GO_pdac table.
UID
O43491
O43491
O43491
O43491
O43491
O43491
Q96C24
Q96C24
Q96C24
Q96C24
Q96C24
…

GO
GO:0003779
GO:0005198
GO:0005886
GO:0008091
GO:0019898
GO:0030866
GO:0005215
GO:0005886
GO:0019898
GO:0030658
GO:0042043
…

Y
1
1
1
1
1
1
1
1
1
1
1
…

We restructured or “flattened” the above table by an SQL
query that transformed GO_merge into another table
GO_merge_flat in which all information about a single protein
appears in one row, as shown in Table 3.
Table 3 The GO_merge_flat table.
UID

The GO_pdac table lists all (UID, GO) pairs, such that UID
is the universal identifier of a pancreatic protein and GO is a
feature descriptor, also called a GO term. The UID and the
GO terms can be found in the UNIPROT database
(www.uniprot.org). There is a many-to-many relationship
between the UIDs and the GO terms. For example, rows three
and five with the same UID O43491 are related to two
different GO terms, GO:0005886 and GO:0019898. On the
other hand, rows three and eight with the same GO term
GO:0005886 are related to two different UIDs, O43491 and
Q96C24.

O43491
Q96C24

0
0
0
3
7
7
9
1
0

0
0
0
5
1
9
8
1
0

0
0
0
5
2
1
5
0
1

0
0
0
5
8
8
6
1
1

0
0
0
8
0
9
1
1
0

0
0
1
9
8
9
8
1
1

0 Y
0
3
0
8
6
6
1 1
0 1

In theory, the number of attributes in the restructured
relation is n+2, where n is the number of distinct GO terms.
Apart from UID and Y, these distinct GO terms form the
attributes of the restructured relation. Below each GO term a
‘1’ or ‘0’ indicates whether the GO term applies to the protein
indicated by the UID on the left.

The GO_np tables listed (UID, GO) pairs of non-pancreatic
Issue 1, Volume 7, 2013

GO
GO:0003779
GO:0005198
GO:0005886
GO:0008091
GO:0019898
GO:0030866
GO:0005215
GO:0005886
GO:0019898
GO:0030658
GO:0042043
…
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create view GOcount(GO,count) as
select GO, count(*)
from GO_merge
group by GO;

D. Simplifying the Restructuring Problem
The restructuring method described in the part C is not
practical because it requires a huge matrix. For example, since
GO_merge table contains 17943 distinct UIDs and 7935
distinct GO terms, a straightforward application of the
restructuring method would yield a table with

The new table GOcount(GO,count) contains the count of
each GO term. We extracted the top 200 most frequent GO
terms into a text file as follows:

17943 x (7935 + 2) ≈ 1.6 x 108
select GO from GOcount
order by count desc limit 200
into outfile `/tmp/MergeTop200GO.txt';

entries. The WEKA and other machine learning systems
simply cannot handle such big matrices. Moreover, the matrix
could become even bigger when we consider not only GO
terms but PFAM families and other attributes as described in
part E below.
One possible way to reduce the size of the matrix is using
Principal Component Analysis. Using Principal Component
Analysis, the matrix could be rewritten into another matrix
with a smaller number of columns. The new columns would be
linear combinations of the existing columns, that is, the 7935
GO terms. While this would reduce the size of the matrix and
alleviate the runtime problems with WEKA and other machine
learning systems, it would still not be a good solution.
Our ultimate goal is to be able to easily and accurately
identify whether a new protein may be associated with cancer.
Intuitively, we would like to characterize the cancer-related
proteins based only on a small subset of the GO terms because
it is impractical to test each of the 7935 GO terms whether it
applies to a new protein. The Principal Component Analysis
would still require that we test each of the 7935 GO terms, and
then linearly combine their (1 or 0) values to find the new
columns. That is why the Principal Component Analysis would
not yield a satisfying solution.
We need another method to find a small subset of the GO
terms that characterizes the proteins in terms of cancerrelatedness as accurately as the entire set of GO terms would
characterize those. How can we find such a subset of the GO
terms?
Luckily, the restructuring matrix would be very sparse
because most of the UIDs are characterized by less than ten
GO terms. Hence most of the 7935 distinct GO terms would
have a value of 0 in most rows. GO terms that occur only
rarely do not connect many different UIDs hence they are not
very useful as efficient cancer indicators.
Hence we experimented with selecting only the top n most
frequent GO terms. We observed that in general when n
increases the accuracy also increases. At some point the
increase in the accuracy diminishes with further increments in
n. Hence it is not worth to increase further the value of n
beyond that point. In our case, this value of n was about 200.
Therefore, in the experiments presented below we selected
only the top 200 most frequent GO terms as follows. First we
found the frequency of each Go terms using the following SQL
query:

Issue 1, Volume 7, 2013

We wrote a C++ program, which is shown in detail in the
APPENDIX, to automatically generate the restructuring SQL
query. Apart from some initialization and ending, the program
repeatedly reads the next GO term from the input file
MergeTop200GO.txt and writes to an output file
SQL_flatten.txt the line of the SQL query that corresponds to
the GO term. Below is how the SQL_flatten.txt file looks like.
select UID,
max(case when GO = `GO:0016021' then 1 else 0 end) as
`GO:0016021',
max(case when GO = `GO:0005515' then 1 else 0 end) as
`GO:0005515',
max(case when GO = `GO:0005634' then 1 else 0 end) as
`GO:0005634',
max(case when GO = `GO:0005737' then 1 else 0 end) as
`GO:0005737',
max(case when GO = `GO:0008270' then 1 else 0 end) as
`GO:0008270',
max(case when GO = `GO:0006350' then 1 else 0 end) as
`GO:0006350',
max(case when GO = `GO:0007165' then 1 else 0 end) as
`GO:0007165',
max(case when GO = `GO:0005886' then 1 else 0 end) as
`GO:0005886',
max(case when GO = `GO:0005524' then 1 else 0 end) as
`GO:0005524',
max(case when GO = `GO:0003677' then 1 else 0 end) as
`GO:0003677',
…
Y
from GO_merge
group by UID
When the above SQL query is executed, for each UID it
checks all the GO terms. If any of the GO terms the UID is
associated with matches a particular GO term for which we are
creating a column in the flattened table, then that GO term will
get a value of ``1" else it will get a value of ``0". The process
then continues until it does not read any more UID groups.
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In Fig. 1, SQL 3 refers to the following query:

E. Merging GO_merge and PFAM_merge

select T.UID,
max(case when GO = `GO:0016021' then 1 else 0 end) as
`GO:0016021',
…
max(case when family = `PF07647' then 1 else 0 end) as
`PF07647'
…
, T.Y
from GO_merge T JOIN PFAM_merge ON T.UID =
PFAM_merge.UID
group by UID

The PFAM table is similar to the GO table. The PFAM
table contains the UID of proteins and the PFAM terms, which
form another set of characterizations of proteins as an
alternative to the GO term characterization. We can create
PFAM_merge by merging PFAM_np and PFAM_pdac
similarly to how we created GO_merge. Fig. 1 outlines the
process of merging the GO_merge and the PFAM_merge
tables together when we need to use both the GO and the
PFAM terms. Table 4 is an example PFAM_merge table. The
SQL query, called SQL 2 in Fig. 1, to generate the
PFAM_merge table is similar to the SQL 1 query we saw
before.

Fig. 1 Generating GO_PFAM_merge.
Table 4 The PFAM_merge table.
UID
P02656
P09651
Q9BY79
Q9BY79
Q9BY79
O95931
Q9UKU0
P10323
Q17RR3
Q17RR3
…
Issue 1, Volume 7, 2013

PFAM
PF05778
PF00076
PF00431
PF01392
PF00057
PF00385
PF00501
PF00089
PF00151
PF01477
…

In our experiments, we used the top n most frequent GO terms
as well as the top m most frequent PFAM terms, yielding a
relation with n+m+2 attributes. We varied the values of n and
m as described in the next section.

Y
0
0
0
0
0
0
0
0
0
0
…

III. EXPERIMENTAL RESULTS
Given a flattened file, as in Table 3, it is easy to generate an
ARFF file, which is needed for the WEKA system. In the
ARFF file, the UID attribute ranges over strings that describe
protein IDs, and the "relation" attribute substitutes for the "Y"
attribute. For example, Table 3 is described using ARFF as
follows:
10
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The classification for all our instance was correct for about
71.7 % of the instances. Below is the confusion matrix:

@relation GO_merge_flat
@attribute ``UID" {O43491, Q96C24}
@attribute ``GO:0003779” {0, 1}
@attribute ``GO:0005198” {0, 1}
@attribute ``GO:0005215” {0, 1}
@attribute ``GO:0005886” {0, 1}
@attribute ``GO:0008091” {0, 1}
@attribute ``GO:0019898” {0, 1}
@attribute ``GO:0030866” {0, 1}
@attribute ``relation" {0, 1}
@data
``O43491",1,1,0,1,1,1,1,1
``Q96C24",0,0,1,1,0,1,0,1

a

b

CLASSIFIED

163

4263

a=0

310

11427

b=1

B. Decision Tree Results
Our next set of experiments used the J48 decision tree. The
decision tree with the GO_merge_flat file gave the following
results:

From our WEKA library, we used the libSVM support
vector machine, which was previously added to the library,
and the J48 decision tree. Both of these accepted input in
ARFF format. The stratified cross-validation was used in all
our classifications.

CORRECTLY CLASSIFIED:
INCORRECTLY CLASSIFIED:

12922

72.017 %

5021

27.983 %

17943

100 %

A. Support Vector Machine Results
TOTAL NUMBER:
Using libSVM with the GO_merge_flat file, WEKA gave
the following:

CORRECTLY CLASSIFIED:
INCORRECTLY CLASSIFIED:
TOTAL NUMBER:

12947

72.156 %

4996

27.844 %

17943

The classification was again about 72 % correct. Below is
the confusion matrix for the J48 decision tree:
a

b
305

a=0

4691

153

b=1

TOTAL NUMBER:

Issue 1, Volume 7, 2013

537

a=0

4484

360

b=1

For decision tree with the PFAM_merge_flat file, the data
mining results were as follows:

CORRECTLY CLASSIFIED:
INCORRECTLY CLASSIFIED:
TOTAL NUMBER:

The confusion matrix displays the relationship between two
or more categorical variables. The number of correctly
classified instances is the sum of the diagonals in the confusion
matrix; all the others are incorrectly classified. For libSVM
with the PFAM_merge file and stratified cross-validation, the
data mining results with were as follows:

INCORRECTLY CLASSIFIED:

12562

CLASSIFIED

12794

CORRECTLY CLASSIFIED:

CLASSIFIED

100 %

WEKA also gave the following confusion matrix:
a

b

11590

71.707 %

4573

28.293 %

16163

11719

72.505 %

4444

27.495 %

16163

100 %

The classification for all our instances was correct for over
72 % of the instances. It was slightly better than for
GO_merge_flat with the decision tree classification. Below is
the confusion matrix for the PFAM_merge decision tree:
a

100 %

11

b

CLASSIFIED

144

4282

a=0

162

11575

b=1

INTERNATIONAL JOURNAL OF BIOLOGY AND BIOMEDICAL ENGINEERING

Table 5. Prostaglandin-related pancreatic proteins.

C. Improving the Accuracy

UID
O15496
O60733
O60760
P02775
P04083
P08047
P09917
P23219
P24557
P34995
P35354
P35408
P41222
P43115
P43116
P47712
Q14684
Q15185
Q16647
Q68DD2
Q92959
Q9H7Z7
Q9NP80
Q9P2B2

As we saw above, for both the GO_merge_flat and the
PFAM_merge_flat files and both the libSVM and the J48 the
accuracy was around 72 %. A natural question is whether the
accuracy can be improved by using both the GO terms and the
PFAM families together. As we saw in Fig. 1, these terms can
be combined in a relation GO_PFAM_merge. This file can be
also flattened and represented in ARFF. We performed another
set
of
experiments
using
WEKA
and
the
GO_PFAM_merge_flat file. The results for the libSVM were
the following:

CORRECTLY CLASSIFIED:
INCORRECTLY CLASSIFIED:
TOTAL NUMBER:

13099

73.003 %

4844

26.997 %

17943

100 %

Finally, the results for J48 were the following:

CORRECTLY CLASSIFIED:
INCORRECTLY CLASSIFIED:
TOTAL NUMBER:

12936

72.095 %

5007

27.905 %

17943

100 %

Name
Group 10 secretory phospholipase A2
Group VI phospholipase A2
Glutathione S-transferase
Platelet basic protein
Phospholipase A2 inhibitory protein
Transcription factor Sp1
Arachidonate 5-lipoxygenase (ALOX5)
Prostaglandin H2 synthase 1(COX-1)
Thromboxane-A synthase
Prostaglandin E2 receptor EP1 subtype
Prostaglandin G/H synthase 2 (COX-2)
Prostaglandin E2 receptor EP4 subtype
Prostaglandin D2 synthase
Prostaglandin E2 receptor EP3 subtype
Prostaglandin E2 receptor EP2 subtype
Cytosolic phospholipase A2
Prostaglandin E synthase
Cytosolic prostaglandin E2 synthase
Prostacyclin synthase
Cytosolic phospholipase A2 zeta
Prostaglandin transporter
Prostaglandin E synthase 2
Ca-independent phospholipase A2-gamma
Prostaglandin F2-alpha receptor regulator

Our results from the GO_PFAM_merge analysis show that
the libSVM has the highest percentage of 73 % compared to
72 % for the decision tree.
IV. PROSTAGLANDIN SYNTHESIS
Several recent studies have identified prostaglandin to be a
major factor in pancreatic cancer [29]-[31]. We retrieved from
the UNIPROT database (www.uniprot.org) all prostaglandinrelated proteins using the following query:
(prostaglandin AND organism:"Homo sapiens [9606]")
AND reviewed:yes
The query retrieved 89 proteins, but many of those were
indicated to belong specifically to the liver, brain or other
organs. By cross-checking with our pancreatic protein
database, we identified the 24 pancreatic and prostaglandinrelated proteins shown in Table 5. The prostaglandin-related
proteins interact with each other as shown in Fig. 2.
Combining all of the information in Table 5 and Fig. 2, we
hypothesize that in pancreatic cancer the following chain of
events takes place, where “anomaly” means either overexpressed or under-expressed.
Issue 1, Volume 7, 2013

Fig. 2 Prostaglandin synthesis [32]
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Y
0
0
0
1
1
1
1
1
0
0
0
1
1
1
1
0
0
1
0
0
1
0
1
1
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VI. CONCLUSION

1. Phospholipase A2 (Q9NP80) anomaly.
2. Arachidonic acid anomaly.
a. COX-1 (P23219) and Prostaglandin H2
anomalies.
i. Prostaglandin D2 synthase (P41222)
anomaly.
ii. Prostaglandin E2 receptors EP2
(P43116), EP3 (P43115), and EP4
(P35408), Prostaglandin E2
synthase (Q15185), and
Prostaglandin F2-alpha receptor
regulator (Q9P2B2) anomalies.
b. ALOX5 (P09917) anomaly.

Further study is needed to develop an early detection
method for pancreatic cancer, enabling earlier treatment of
cancer patients, and thereby increase their survival rate, which
is currently one of the lowest among cancer patients.
The result that the functional characterizations of proteins
by either GO terms or PFAM families enable a good
prediction of pancreatic cancer link may be also generalized to
other types of cancers. The putative role of Q9NP80 in the
early stages of pancreatic cancer should be further
investigated.
APPENDIX
Below is the C++ program which helps us to generate
automatically the written SQL queries that are used for data
restructuring:

Due to various feedback loops, anomalies at some point in a
chain may be compensated. In pancreatic cancer, we do not
see further anomalies in the right-side chain of Fig. 2 starting
with HPETE because Glutathione S-transferase (O60760) is
not elevated. Similarly, we have little evidence for anomaly in
the two other branches starting from Prostaglandin H2 because
neither Prostacyclin synthase (Q16647) nor Thromboxane-A
synthase (P24557) is anomalous. Hence the hypothetical
process of pancreatic cancer can be summarized as follows:

#include <iostream>
#include <fstream>
#include <string>
using namespace std;
int main()
{
string line;

Q9NP80 → P23219 → P41222
↓
Q15185 → Q9P2B2

ifstream ifs("MergeTop200GO.txt");
ofstream myfile ("SQL_flatten.txt", ios::app);

V. DISCUSSION OF THE RESULTS

if (ifs.good())
// If opening is successful
{
myfile "select UID , \n"; // output the first line

The results reveal that the characterizations of the
pancreatic proteins by either GO terms or PFAM families can
be used to predict with a good, that is, around 72 %, accuracy
whether they are involved in cancer. Since the characterization
of proteins is mainly based on their biological functions, the
results imply that the likelihood of a protein being involved in
cancer depends on its particular functions. Although the 72 %
accuracy is interesting, for medical applications a higher, over
90 %, accuracy would be necessary. It is not clear how that
higher accuracy could be achieved. Our second set of
experiments with both GO terms and PFAM families together
gave a slight increase in accuracy to 73 % in the case of
libSVM. It is possible that by adding even more protein
attributes, the accuracy of classification would improve
further.
It appears that proteins involved in certain general functions
or particular protein networks within cells are more likely to
be associated with cancer. It appears that within these
particular protein synthesis networks entire pathways may be
predisposed to anomalous behavior and cause cancer. In
particular, we gave an in-depth study of the prostaglandin
protein synthesis network. We are not aware of any previous
work that called attention to the identified pathways starting
from Q9NP80, although the anomalous behavior of Q9NP80
may be traced further back in an expanded network.
Issue 1, Volume 7, 2013

while(getline(ifs,line))
// read each line until EOL
{
myfile >> "max(case when GO = \" >> line >>
"\ then 1 else 0 end) as \" >> line >> "\," >> endl;
}
// end-while
myfile >> "Y \ n";
myfile >> "from GO_merge \n";
myfile >> "group by UID \n";
myfile.close();
ifs.close();
// close the file
}
else
cout >> "ERROR: can't open file!!!" >> endl;
return 0;
}
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